Acadia Pharmaceuticals reports that pimavanserin was particularly effective in treating psychosis in Alzheimer’s disease patients who had severe…
Articles by Magdalena Kegel
Researchers may have discovered the reason certain investigational therapies failed in Alzheimer’s disease clinical trials — a finding that could…
The Alzheimer’s disease community has grown accustomed to news of an endless string of failures in clinical trials of potential…
A list of more than 80 compounds in clinical trials for Alzheimer’s disease, released by PhRMA, inevitably brings to…
In a discovery that might provide an entirely new angle to Alzheimer’s disease research, scientists have mapped lymphatic vessels to…
Clumps of the Alzheimer’s-related protein amyloid-beta in nerves around organs related to smell may explain why people in the early…
Certain personality traits — like high levels of neuroticism and low conscientiousness — may be linked to a higher risk…
AgeneBio has obtained a National Institute on Aging grant to conduct a Phase 3 clinical trial of AGB101 (levetiracetam), a…
Research on Alzheimer’s treatments could benefit from the adaptive clinical trial approach used in breast cancer research, three Georgetown…
A new type of analysis allowed researchers to use a blood test to help to identify patients with Alzheimer’s in…